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TECHNICAL REPORT
PROTOCOL FOR DNA EXTRACTION OF Cryptosporidium spp. OOCYSTS IN FECAL SAMPLES
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SUMMARY
Molecular characterization of Cryptosporidium spp. oocysts in clinical samples is useful for public health since it allows the
study of sources of contamination as well as the transmission in different geographical regions. Although widely used in developed
countries, in Brazil it is restricted to academic studies, mostly using commercial kits for the extraction of genomic DNA, or in
collaboration with external reference centers, rendering the method expensive and limited. The study proposes the application of
the modifications recently introduced in the method improving feasibility with lower cost. This method was efficient for clinical
samples preserved at -20 °C for up to six years and the low number of oocysts may be overcomed by repetitions of extraction.
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The genus Cryptosporidium has several species and genotypes that
infect different hosts. At present the species recognized by many
researchers as causing human cryptosporidiosis are: C. parvum (C.
parvum bovine genotype or genotype 2 or genotype C or type II) and
C. hominis (C. parvum human genotype or genotype 1 or genotype H
or type I), responsible for most of the human infections; C. felis, C.
meleagridis and C. canis (C. type dog) reported in immunocompetent
patients; and C. muris, C. baileyi, C. felis, C. meleagridis, C. canis, C.
suis (C. type pig) related to immunosuppressed patients4,5,23,27,29,30.
Cryptosporidiosis represents a great public health issue, because
many cases are asymptomatic, there is no effective clinical treatment
and it may be fatal in immunocompromised individuals11,17,27.
Epidemiologic studies on human cryptosporidiosis are made difficult
by the different transmission pathways and by the limitation in
identifying species using conventional methods, such as staining and
immunological tests5,11. Progress in molecular techniques produced a
great impact on the knowledge of taxonomy, biology, pathogenesis,
epidemiology and transmission of the agent and also on evaluation of
cryptosporidiosis treatment, as well as helping epidemiologists
regarding control and determination of infection sources4,5,14,17,30 . Thus,
among the molecular methods developed for the detection and
differentiation of different Cryptosporidium species and genotypes,
PCR is the mostly used for both clinical and environmental samples8,11,
28
, but its sensitivity is affected by the presence of inhibitors existing
in fecal samples which may be minimized with changes in the extraction
protocol6,8,10,15,16,22,26. In Brazil, most laboratories do not identify
Cryptosporidium spp. oocysts routinerely7,15 and there is no
standardization of molecular techniques for genotypic characterization
in isolated samples of fecal material. This suggests that information
about circulating species and genotypes are scarce in our
country1,2,3,6,12,13,14,15. Preservation of fecal samples for molecular
analysis may be performed in 2.5% potassium dichromate at
4 °C10,12,14,18, in absolute ethanol at room temperature19,22, in 10%
formalin18,31, under refrigeration at 4 °C23, at -20 °C21,28 or at -80 °C24
or else, after a drying process with silica21. There are reports on the
inhibitory effects of potassium dichromate and formalin on PCR that
may lead to a false-negative result of this reaction18,19,25. Another factor
that may contribute to non-amplification of the fragment of interest,
mainly in Cryptosporidium study, may be inadequate DNA extraction
from fecal samples31.
Aliquots of fecal samples selected from the diagnostic routine of
the Parasitology Service of Division of Central Laboratory, “Hospital
das Clínicas”, University of São Paulo Medical School, during the
period of February 2000 to June 2006, were distributed in 1.5 mL
microtubes and preserved in 10% buffered formalin at the 1:3
proportion, under refrigeration (4 °C) and “in natura” frozen at -20 °C.
Cryptosprodium spp. oocysts were detected by the modified Kinyoun
method15, in smears prepared with 10 µL of fecal sample “in natura”
or, in a small proportion and when formed fecal samples, in buffered
formalin, on 76 x 26 mm glass slides for microcopy, fixed with methanol
PA. When detected, they were measured with the help of an ocular
micrometer during reading under a light microscope, 100x objective,
and for each slide the mean was calculated. The amount of oocysts
was estimated as 1+ (1-10 oocysts/smear); 2+ (10 ≤ 50 oocysts/smear);
166
GONÇALVES, E.M.N.; ARAÚJO, R.S.; ORBAN, M.; MATTÉ, G.R.; MATTÉ, M.H. & CORBETT, C.E.P. - Protocol for DNA extraction of Cryptosporidium spp. oocysts in fecal samples.
Rev. Inst. Med. trop. S. Paulo, 50(3) : 165-167, 2008
and 3+ (> 50 oocysts/smear). For all fecal samples positive for
Cryptosporidium spp. during reading under a light microscope, aliquots
“in natura” (-20 °C) were defrosted to room temperature and diluted
in deionized water, at a 1:1 proportion, in 2 mL tubes, to a final volume
of 200 µL; to this fecal sample 500 µL lysis buffer [50 µ; Tris - HCl
100 mM (pH = 8.0); 50 µL EDTA 50 mM (pH = 8.0); 50 µL 10% SDS;
3.5 µL 70 mM β-mercaptoethanol; 1 µL 1% polyvinylpyrrolidone
(PVP); 345.5 µL ultra-pure water (Milli-Q)] were added and incubated
for 90 minutes in a 65 °C water bath. After incubation 20 µL proteinase
K (20 mg/mL) were added to each tube, being again incubated for a
period of 120 minutes at the same temperature. The samples were
incubated in an ice bath for 15 minutes. DNA was extracted with 500
µL phenol-chloroform-isoamyl alcohol (24:25:1), the tubes were
homogenized and the mixture was transferred to Phase Lock Gel light
(Eppendorf®, Germany) tubes which were centrifuged at 12,000 rpm
for five minutes at 4 °C. The aqueous phase, present at the surface,
was transferred to a new microtube, 500 µL chloroform were added,
homogenized and centrifuged at 12,000 rpm for 15 minutes at 4 °C.
The supernatant was transferred to another microtube and precipitated
with 500 µL ice-cold isopropyl alcohol and maintained in an ice bath
for 10 minutes, centrifuged at 12,000 rpm, for three minutes at 4 °C.
The supernatant was carefully discarded and the precipitated DNA
washed with 500 µL 70% ethyl alcohol and centrifuged at 12,000 rpm,
for three minutes at 4 °C. The supernatant was discarded and the DNA
dried under vacuum, eluted with 50 µL TE buffer and maintained at
4 °C until utilization for amplification of the fragment of interest,
according to the protocol described by COUPE et al9. In this protocol,
lysis of the oocyst wall and DNA extraction was performed in fecal
samples stored at -20 °C which suffered two subsequent incubations:
one for rupture and the other for digestion of the oocyst cell wall.
First, they were incubated with the lysis solution (Tris-HCl + EDTA +
10% SDS + β-mercaptoethanol). EDTA starts cell wall rupture, Tris-
HCl equilibrates the pH (= 8.0) assuring lysis, SDS acts on the
membrane lipid layer, and β-mercaptoethanol delays DNA oxidation
facilitating its recovery. Incubation was performed with proteinase K,
promoting cell wall digestion. For DNA extraction phenol-chloroform-
isoamyl alchol (24:25:1) was used. Phenol-chloroform denaturizes
proteins that form an interface layer between the aqueous and organic
phases, the DNA being retained in the aqueous phase. Isoamyl alcohol
removes organic residues and precipitates DNA in the aqueous solution.
The step of removal of the aqueous phase was a critical point during
the test since the interface layer could not be transferred due to the
fact that, when in contact with alcohol, a permanent DNA precipitate
was formed which made its posterior amplification impossible. This
problem was eliminated by the introduction of the Phase Lock Gel
light tube (Eppendorf®, Germany) in the separation step of the aqueous
and organic phases. Introduction of PVP that assures efficient removal
of inhibitors that may co precipitate with DNA during extraction after
treatment with a lysis solution, improved the final amplification. Among
the factors which may result in non-amplification by PCR are: the
fecal sample containing variable concentrations of inhibitory substances
such as biliary salts, proteins, polysaccharide complexes, bilirubins
and phenolic compounds, depending on diet, intestinal flora and health
conditions of the host, or, also, presence of a small number of oocysts,
not uniformly distributed in the fecal sample, or not present in the
aliquot separated for extraction, implying absence of target DNA, and
also inadequate preservation or degradation of the DNA during storage.
The used fecal samples were stored at -20 °C eliminating possible
inhibitory effects by potassium dichromate and formalin on PCR18,19,23,
and the intrinsic inhibitors were minimized using PVP. Although the
literature reports an inverse relationship between time of storage of
the fecal sample and quality of extracted DNA with subsequent loss of
sensitivity of PCR26, preliminary results (data not shown) demonstrated
that no statistically significant correlation was obtained (p > 0.05) for
year of collection, result that corroborates to those of NSUBUGA et
al.22 who also did not observe interference on their results on analyzing
samples conserved for 33 months. A study performed by LIMOR et
al.20, with samples preserved with dichromate for one year, did not
reveal interference of the preserver on the PCR reaction in real time.
In the study performed by HIGGINS et al.16 was observed decrease in
sensitivity of the PCR reaction in real time for samples preserved for
three months in formalin. Most samples examined in this study for
morphologic detection presented a small amount of oocysts (maximum
of 10 oocysts/10 µL fecal sample) and additional tests were performed
in five replica for DNA extraction and the final products were mixed
and then subjected to PCR reaction, which increased concentration of
material and guaranteed product amplification (data not shown). This
strategy was used by XIAO et al.28 increasing PCR efficacy from 62%
to 86% in environmental samples with a low number of present oocysts,
increasing also the possibility of detection of multiple genotypes in
surface waters. We believe that the low number of Cryptosporidium
oocysts detected on microscopy influences the result, probably due to
the heterogeneous distribution in the sample or even by preserving
aliquots without the target DNA. Discrepant results between microscopy
and PCR were reported by MAGI et al.21 who detected in their samples
20% positivity by PCR, due to the presence of few oocysts distributed
in a non-homogeneous form in the analyzed fecal material, similarly
to PENG et al.24 with 35.3% positivity suggesting long storage time in
formalin of the seventeen fecal samples studied. The general data
obtained by PCR (37.23%) in this study resulted extremely positive
when compared with those derived from former partnerships performed
with protocols sedimented for PCR, in addition to the use of commercial
kits for DNA extraction and which resulted in 49.2% and 20.9%
amplification of samples15. The technique here used demonstrates its
utilization in this context, once being associated with RFLP using only
two restriction enzymes, is able to distinguish C. hominis and C. parvum
(data not shown), responsible for most human infections from other
related species, despite failures observed in samples with a low number
of oocysts during microscopic screening, which may be overcomed
with repetition of extractions.
RESUMO
Protocolo para extração de DNA de oocistos de Cryptosporidium
spp. em amostras fecais
A caracterização molecular de oocistos de Cryptosporidium spp.
em amostras clínicas é útil à saúde pública, pois permite estudo das
fontes de contaminação e a transmissão em determinadas regiões
geográficas. Apesar de largamente utilizada em países desenvolvidos,
no Brasil está restrita aos estudos acadêmicos, na maioria utilizando
kits comerciais para extração do DNA genômico, ou em colaborações
com centros de referência externos, o que torna o método caro e
limitado. Este estudo propõe a introdução de modificações nos métodos
existentes para melhorar a viabilidade e baixar custos. O método
proposto foi eficiente em amostras clínicas preservadas a -20 °C por
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até seis anos e o baixo número de oocistos pode ser contornado por
replicadas extrações de DNA.
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